Mohamed Khairie Issa's most recent trade in Incyte Corp. was a trade of 27,812 Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte | Mohamed Khairie Issa | EVP, Head of US Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 27,812 | 76,483 (0%) | 0% | 0 | Common Stock | |
| Incyte | Mohamed Khairie Issa | EVP, Head of US Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 48,671 | 48,671 (0%) | 0% | 0 | Common Stock |